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Background: HDL lipoprotein particles (HDLp) and Interleukin-6 (Il-6) are associated with cardiovascular (CVD) hospitalization and death. We 
studied the predictive value of small HDLp and Il-6 for deaths and hospitalizations that included an “other” diagnosis, that is, non-CVD, non-cancer 
cause thought to include in common an important inflammatory component in subjects free of overt CVD.
Methods: A fasting blood sample was taken for the analysis of lipids, lipoprotein particles and Il-6 in the MESA study population (n = 6499, age 
range 45-84 years). CVD and “other” outcomes hospitalization and death were followed for median 8 years. Using proportional hazards regression 
we studied the association of small HDLp and Il-6 with “other” and CVD outcomes after adjustment of age, race, gender, center, height, BMI, 
blood pressure, heart rate, smoking status, diabetes, blood pressure, other lipoprotein particle concentrations, blood total and HDL cholesterol, 
triglycerides, antihypertensive medication, lipid-lowering medication.
Results: Adjusted hazard ratios (HR) per standard deviation (SD) of the concentration of each predictor are summarized in table 1. The results 
were attenuated compared with models that did not adjust for other covariates.
Conclusions: In subjects free of overt CVD, small HDLp and Il-6 are independently predicitive for death and hospitalization for non-CVD, noncancer 
cause. For CVD hospitalization and death, IL-6 is independently predictable, while HDLp not. 
Table 1: HRs and 95 % CI for the indicated outcome after adjusment for baseline covariates
Predictor
ICD-based
“other” death
ICD-based “other” 
hospitalization
Adjudicated CVD hospitalization 
and death
(mean ± SD)
(N participants with event 
= 154)
(N participants with event = 
2037)
(N participant with event = 583)
HR (95 % CI) P HR (CI) P HR (CI) P
Small HDLp
(19.6 ± 4.7 
mmmol/L)
0.77 (0.63, 0.94 0.009 0.89 (0.85, 0.94) <0.0001 0.92 (0.83, 1.01) 0.08
Il-6
(1.6 ± 1.2 pg/mL)
1.23 (1.11, 1.37) 0.0002 1.05 (1.00, 1.09) 0.045 1.11 (1.04, 1.20) 0.004
